Neuland Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Neuland Laboratories Ltd · Outcome · 03 Nov 2026, 9:18 pm
Neuland Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 44,966 (-12.6% YoY | -29.9% QoQ) ■ EBITDA: 9,756 (-37.3% YoY | -56.2% QoQ) ■ EBITDA Margin (%): 21.7 (-855 bps YoY | -1304 bps QoQ) ■ PAT: 5,163 (-46.7% YoY | -65.0% QoQ) ■ EPS (INR): 40.2 (-46.7% YoY | -65.0% QoQ)
Original exchange filing (PDF)
More announcements from Neuland Laboratories Ltd
- Intimation about Schedule of Analyst / Institutional Investor Meeting on November 17, 2026 · 06 Nov 2026
- Change in Corporate Office Address of Registrar and Share Transfer Agent (RTA) · 05 Nov 2026
- Audio Recording of the Earnings call conducted on November 3, 2026 · 04 Nov 2026
- Investor Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Press Release on the Financial Results of the Company for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Disclosure under Regulation 30 of SEBI Listing Regulations · 03 Nov 2026
- Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Neuland Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 03 Nov 2026
